Clinical Trials Logo

Thymoma and Thymic Carcinoma clinical trials

View clinical trials related to Thymoma and Thymic Carcinoma.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03663764 Active, not recruiting - Clinical trials for Thymoma and Thymic Carcinoma

Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor

Start date: August 13, 2018
Phase: Phase 2
Study type: Interventional

This phase II study was to assess the efficacy and toxicity of hypofractionated radiotherapy (HRT) combined with weekly docetaxel/platinum and thymosin α1 in patients with unresectable or recurrent thymic epithelia tumors (TETs).